Meta-analysis of these studies revealed that patients who died from COVID-19 had significantly higher levels of syndecan-1, compared with those who survived (SMD 1.22, 95% CI 0.10 to 2.33, P = 0.03). Here, SDC1 is linked to COVID-19.